Academic achievement varies with gestational age among children born at term

Kimberly G Noble1, William P Fifer, Virginia A Rauh

  • 1Department of Pediatrics, Columbia University, 630 W. 168th St, P&S Box 16, New York, NY 10033, USA. kgn2106@columbia.edu

Pediatrics
|July 4, 2012
PubMed

Insights

Children born earlier in the normal term range (37-38 weeks gestation) had lower school achievement in reading and math compared to those born at 39-41 weeks. This finding was independent of other factors.

Area of Science:

  • Perinatal health
  • Developmental pediatrics
  • Educational psychology

Background:

  • Gestational age is a critical factor in child development.
  • The "normal term" range (37-41 weeks) encompasses significant developmental variation.
  • Previous research has not fully elucidated school achievement differences within this normal term range.

Purpose of the Study:

  • To investigate school achievement variations in children born between 37 and 41 weeks' gestation.
  • To determine if gestational age within the normal term range impacts third-grade reading and math abilities.
  • To assess the influence of social and biological factors on this relationship.

Main Methods:

  • Analysis of 128,050 singleton births in a large US city.
  • Matching birth records with third-grade standardized test scores.
  • Statistical assessment of gestational age and mediating factors on academic outcomes.

Main Results:

  • A significant positive association was found between later gestational age (39-41 weeks) and higher third-grade reading and math scores.
  • Children born at 37-38 weeks gestation demonstrated significantly lower academic achievement.
  • This association persisted independently of birth weight and other socioeconomic/obstetric variables.

Conclusions:

  • Earlier normal term birth (37-38 weeks) is linked to poorer school performance.
  • Gestational age within the normal term range is a potential indicator for identifying at-risk children.
  • This information can inform researchers, clinicians, and parents about potential developmental trajectories.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when researchers try to extrapolate results...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...